Sage Therapeutics Inc (SAGE) — Cash Flow Reinvestment Rate
Sage Therapeutics Inc (SAGE) has a Cash Flow Reinvestment Rate of 0.05x as of December 2020, reinvesting $45.52 Million (capex $1.00K plus investments $45.52 Million) from operating cash flow of $1.01 Billion. See Sage Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sage Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Sage Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Sage Therapeutics Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Sage Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Sage Therapeutics Inc. See Sage Therapeutics Inc (SAGE) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.67x | $443.37 Million | $664.28 Million | $345.00K | — |